Temporal, spatial of and cell type-specified control of cre-mediated DNA recombination in transgenic mice

Nature Biotechnology

Volumn 17, Issue 11, 1999, Pages 1091-1096

  Utomo, Ahmad R H ^a   Nikitin, Alexander Yu ^a   Lee, Wen Hwa ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Conditional gene regulation; Cre recombinase; Mammary gland; Tetracycline controlled transactivator; Whey acidic protein

Indexed keywords

ANIMAL CELL; ARTICLE; CELL SPECIFICITY; CELL TYPE; DNA RECOMBINATION; GENE CONTROL; GENE EXPRESSION; GENE INACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSGENIC MOUSE;

ANIMALS; DOXYCYCLINE; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; INTEGRASES; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); RECOMBINATION, GENETIC; TETRACYCLINE; TRANS-ACTIVATORS; TRANSGENES; VIRAL PROTEINS;

EID: 0032692949     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/15073     Document Type: Article

References (64)

1. Porter, A. Controlling your losses: conditional gene silencing in mammals. Trends Genet. 14, 73-79 (1998).
2. Sauer, B. Inducible gene targeting in mice using the Cre/lox system. Methods 14, 381-392 (1998).
3. Gu, H., Zou, Y.R. & Rajewsky, K. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 73, 1155-1164 (1993).
4. Lakso, M. et al. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc. Natl. Acad. Sci. USA 89, 6232-6236 (1992).
5. O'Gorman, S., Fox, D.T. & Wahl, G.M. Recombinase-mediated gene activation and site-specific integration in mammalian cells. Science 251, 1351-1355 (1991).
6. Dymecki, S.M. Flp recombinase promotes site-specific DMA recombination in embryonic stem cells and transgenic mice. Proc. Natl. Acad. Sci. USA 93, 6191-6196 (1996).
7. Buchholz, F., Ringrose, L., Angrand, P.O., Rossi, F. & Stewart, A.F. Different thermostabilities of FLP and Cre recombinases: implications for applied site-specific recombination. Nucleic Acids Res. 24, 4256-4262 (1996).
8. Buchholz, F., Angrand, P.O. & Stewart, A.F. Improved properties of FLP recombinase evolved by cycling mutagenesis. Nat. Biotechnol. 16, 657-662 (1998).
9. Kühn, R., Schwenk, F., Aguet, M. & Rajewsky, K. Inducible gene targeting in mice. Science 269, 1427-1429 (1995).
10. No, D., Yao, T.P. & Evans, R.M. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. USA 93, 3346-3351 (1996).
11. Schwenk, F., Kühn, R., Angrand, P.O., Rajewsky, K. & Stewart, A.F. Temporally and spatially regulated somatic mutagenesis in mice. Nucleic Acids Res. 26, 1427-1432 (1998).
12. Danielian, P.S., Muccino, D., Rowitch, D.H., Michael, S.K. & McMahon, A.P. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr. Biol. 8, 1323-1326 (1998).
13. Zhang, Y. et al. Inducible site-directed recombination in mouse embryonic stem cells. Nucleic Acids Res. 24, 543-548 (1996).
14. Brocard, J. et al. Spatio-temporally controlled site-specific somatic mutagenesis in the mouse. Proc. Natl. Acad. Sci. USA 94, 14559-14563 (1997).
15. Kellendonk, C. et al. Regulation of Cre recombinase activity by the synthetic steroid RU 486. Nucleic Acids Res. 24, 1404-1411 (1996).
16. Kellendonk, C. et al. Inducible site-specific recombination in the brain. J. Mol. Biol. 285, 175-182 (1999).
17. Shibata, H. et al. Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 278, 120-123 (1997).
18. Akagi, K. et al. Cre-mediated somatic site-specific recombination in mice. Nucleic Acids Res. 25, 1766-1773 (1997).
19. Lee, Y.H., Sauer, B., Johnson, P.F. & Gonzalez, F.J. Disruption of the c/ebp alpha gene in adult mouse liver. Mol. Cell. Biol. 17, 6014-6022 (1997).
20. Wakita, T. et al. Efficient conditional transgene expression in hepatitis C virus cDNA transgenic mice mediated by the Cre/loxP system. J. Biol. Chem. 273, 9001-9006 (1998).
21. Wang, Y., Krushel, L.A. & Edelman, G.M. Targeted DNA recombination in vivo using an adenovirus carrying the Cre recombinase gene. Proc. Natl. Acad. Sci. USA 93, 3932-3936 (1996).
22. Burcin, M.M., Schiedner, G., Kochanek, S., Tsai, S.Y. & O'Malley, B.W. Adenovirus-mediated regulable target gene expression in vivo. Proc. Natl. Acad. Sci. USA 96, 355-360 (1999).
23. Kafri, T. et al. Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy. Proc. Natl. Acad. Sci. USA 95, 11377-11382 (1998).
24. Anderson, W.F. Human gene therapy. Nature 392, 25-30 (1998).
25. Morsy, M.A. et al. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc. Natl. Acad. Sci. USA 95, 7866-7871 (1998).
26. St-Onge, L., Furth, P.A. & Gruss, P. Temporal control of the Cre recombinase in transgenic mice by a tetracycline responsive promoter. Nucleic Acids Res. 24, 3875-3877 (1996).
27. Gossen, M. & Bujard, H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89, 5547-5551 (1992).
28. Furth, P.A. et al. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc. Natl. Acad. Sci. USA 91, 9302-9306 (1994).
29. Passman, R.S. & Fishman, G.I. Regulated expression of foreign genes in vivo after germline transfer. J. Clin. Invest. 94, 2421-2425 (1994).
30. Gossen, M. et al. Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769 (1995).
31. Kistner, A. et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA 93, 10933-10938 (1996).
32. Böcker, R., Warnke, L. & Estler, C.J. Blood and organ concentrations of tetracycline and doxycycline in female mice. Comparison to males. Arzneimittelforschung 34, 446-448 (1984).
33. Wivagg, R.T., Jaffe, J.M. & Colaizzi, J.L. Influence of pH and route of injection on acute toxicity of letracycline in mice. J. Pharm. Sci. 65, 916-918 (1976).
34. Blau, H.M. & Rossi, F.M.V. Tet B or not tet B: advances in tetracycline-inducible gene expression. Proc. Natl. Acad. Sci. USA 96, 797-799 (1999).
35. Schultze, N., Burki, Y., Lang, Y., Certa, U. & Bluethmann, H. Efficient control of gene expression by single step integration of the tetracycline system in transgenic mice. Nat. Biotechnol. 14, 499-503 (1996).
36. Chrast-Balz, J. & Hooft van Huijsduijnen, R. Bi-directional gene switching with the tetracycline repressor and a novel tetracycline antagonist. Nucleic Acids Res. 24, 2900-2904 (1996).
37. Hofmann, A., Nolan, G.P. & Blau, H.M. Rapid retroviral delivery of tetracycline-inducible genes in a single autoragulatory cassette. Proc. Natl. Acad. Sci. USA 93, 5185-5190 (1996).
38. A-Mohammadi, S. & Hawkins, R.E. Efficient transgene regulation from a single tetracycline-controlled positive feedback regulatory system. Gene Ther. 5, 76-84 (1998).
39. Harding, T.C., Geddes, B.J., Murphy, D., Knight, D. & Uney, J.B. Switching transgene expression in the brain using an adenoviral tetracycline-regulatable system. Nat. Biotechnol. 16, 553-555 (1998).
40. Hong, F.D. et al. Structure of the human retinoblastoma gene. Proc. Natl. Acad. Sci. USA 86, 5502-5506 (1989).
41. Tsien, J.Z. et al. Subregion- and cell type-restricted gene knockout in mouse brain. Cell 87, 1317-1326 (1996).
42. Zinyk, D.L., Mercer, E.H., Harris, E., Anderson, D.J. & Joyner, A.L Fate mapping of the mouse midbrain-hindbrain constriction using a site-specific recombination system. Curr. Biol. 8, 665-668 (1998).
43. Baron, U. et al. Generation of conditional mutants in higher eukaryotes by switching between the expression of two genes. Proc. Natl. Acad. Sci. USA 96, 1013-1018 (1999).
44. Baron, U., Gossen, M. & Bujard, H. Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res. 25, 2723-2729 (1997).
45. Al-Ali, W., Bissada, N.F. & Greenwell, M. The effect of local doxycycline with and without tricalcium phosphate on the regenerative healing potential of periodontal osseous defects in dogs. J. Periodontol. 60, 582-590 (1989).
46. Webster, G.F., Toso, S.M. & Hegemann, L. Inhibition of a model of in vitro granuloma formation by tetracyclines and ciprofloxacin. Involvement of protein kinase C. Arch. Dermatol. 130, 748-752 (1994).
47. Larsen, T. In vitro release of doxycycline from bioabsorbable materials and acrylic strips. J. Periodontol. 61, 30-34 (1990).
48. Golub, L.M., Ciancio, S., Ramamamurthy, N.S., Leung, M. & McNamara, T.F. Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans. J. Periodontal Res. 25, 321-330 (1990).
49. Bignon, Y.J. et al. Expression of a retinoblastoma transgene results in dwarf mice. Genes Dev. 7, 1654-1662 (1993).
50. Chang, C.Y., Riley, D.J., Lee, E.Y. & Lee, W.H. Quantitative effects of the retinoblastoma gene on mouse development and tissue-specific tumorigenesis. Cell Growth Differ. 4, 1057-1064 (1993).
51. Lee, W.H. et al. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235, 1394-1399 (1987).
52. Friend, S.H. et al. A human DNA segment with properties of the gene that pre-disposes to retinoblastoma and osteosarcoma. Nature 323, 643-646 (1986).
53. Nikitin, A.Y., Juárez-Pérez, M.I., Li, S., Huang, L. & Lee, W.-H. RB-mediated suppression of multiple neuroendocrine neoplasia and lung metastases in Rb+/-mice. Proc. Natl. Acad. Sci. USA 96, 3916-3921 (1999).
54. Cordon-Cardo, C. & Richon, V.M. Expression of the retinoblastoma protein Is regulated in normal human tissues. Am. J. Pathol. 144, 500-510 (1994).
55. Szekely, L. et al. Cell type and differentiation dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses. Cell Growth Differ. 3, 149-156 (1992).
56. Soriano, P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21, 70-71 (1999).
57. Wagner, K.U. et al. Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res. 25, 4323-4330 (1997).
58. Bayna, E.M. & Rosen, J.M. Tissue-specific, high level expression of the rat whey acidic protein gene in transgenic mice. Nucleic Acids Res. 18, 2977-2985 (1990).
59. Pittius, C.W. et al. A milk protein gene promoter directs the expression of human tissue plasminogen activator cDNA to the mammary gland in transgenic mice. Proc. Natl. Acad. Sci. USA 85, 5874-5878 (1988).
60. Gu, H., Marth, J.D., Orban, P.C., Mossmann, H. & Rajewsky, K. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265, 103-106 (1994).
61. Lakso, M. et al. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl. Acad. Sci. USA 93, 5860-5865 (1996).
62. Bonnerot, C. & Nicolas, J.F. Application of LacZ gene fusions to postimplantation development. Methods Enzymol. 225, 451-469 (1993).
63. Nikitin, A.Y. & Lee, W.H. Early loss of the retinoblastoma gene is associated with impaired growth inhibitory innervation during melanotroph carcinogenesis in Rb+/-mice. Genes Dev. 10, 1870-1879 (1996).
64. Nikitin, A.Y, Rajewsky, M.F. & Pozharisski, K.M. Development of malignant fibrous histiocytoma induced by 7,12-dimethylbenz[a]anthracene in the rat: characterization of early atypical cells. Virchows Arch. B 64, 151-159 (1993).